Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers
- 1 March 1994
- journal article
- clinical trial
- Published by Springer Nature in Psychopharmacology
- Vol. 114 (2) , 257-261
- https://doi.org/10.1007/bf02244846
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- CCK in animal and human research on anxietyTrends in Pharmacological Sciences, 1993
- A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorderBiological Psychiatry, 1992
- CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sitesNeuroReport, 1992
- L-365,260, a CKKB receptor antagonist, blocks CCK-4-panic disorderEuropean Neuropsychopharmacology, 1992
- Feasibility of reversing benzodiazepine tolerance with flumazenilThe Lancet, 1991
- Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristicsBehavioural Brain Research, 1990
- Pharmacology of Dormicum (midazolam) and Anexate (flumazenil)Acta Anaesthesiologica Scandinavica, 1990
- Midazolam and flumazenil: the agonist-antagonist concept for sedation and anaesthesiaActa Anaesthesiologica Scandinavica, 1990
- Behavioral characteristics of centrally administered adenosine analogsPharmacology Biochemistry and Behavior, 1986
- Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neuronesNature, 1984